Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
9(39%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_2
2
9%
Ph phase_1
1
4%
Ph not_applicable
20
87%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
1(4.3%)
Phase 2Efficacy & side effects
2(8.7%)
N/ANon-phased studies
20(87.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

9

trials recruiting

Total Trials

23

all time

Status Distribution
Active(14)
Completed(5)
Terminated(1)
Other(3)

Detailed Status

Recruiting9
Completed5
Not yet recruiting4
unknown2
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
9
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (4.3%)
Phase 22 (8.7%)
N/A20 (87.0%)

Trials by Status

withdrawn14%
completed522%
not_yet_recruiting417%
recruiting939%
unknown29%
enrolling_by_invitation14%
suspended14%

Recent Activity

9 active trials
Showing 5 of 23
recruitingphase_2

Investigation to Understand and Optimize Psilocybin

NCT06512194
recruitingphase_1

The ENHANCE Study: taVNS and Psilocybin

NCT05866471
recruitingnot_applicable

FR-taVNS Tinnitus Tria

NCT07711639
recruitingnot_applicable

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT

NCT07711626
withdrawnnot_applicable

How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?

NCT07457372
View all 23 trials

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT06512194Phase 2

Investigation to Understand and Optimize Psilocybin

Recruiting
NCT05866471Phase 1

The ENHANCE Study: taVNS and Psilocybin

Recruiting
NCT07711639Not Applicable

FR-taVNS Tinnitus Tria

Recruiting
NCT07711626Not Applicable

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT

Recruiting
NCT07457372Not Applicable

How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?

Withdrawn
NCT03603730Not Applicable

Vagal Nerve Stimulation for Interoception Modulation

Completed
NCT07673146Not Applicable

Probing Gut-Brain Communication in Parkinson's Disease

Not Yet Recruiting
NCT06127550Not Applicable

taVNS for Letter Learning in Dyslexia

Suspended
NCT07132021Not Applicable

Efficacy of Trans-auricular Vagus Nerve Stimulation on Upper Extremity Motor Recovery in Stroke Survivors

Recruiting
NCT07563387Not Applicable

taVNS for Speech and Language Recovery in Aphasia

Enrolling By Invitation
NCT04065386Not Applicable

Transcutaneous Auricular Vagal Nerve Stimulation for Post-coma Patients With Disorders of Consciousness

Completed
NCT07526402Not Applicable

Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals

Not Yet Recruiting
NCT07500012Not Applicable

taVNS for Breast Cancer Pain and Symptom Management

Recruiting
NCT07458646Not Applicable

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Perioperative Negative Emotions in Breast Cancer Surgery Patients

Not Yet Recruiting
NCT07366411Phase 2

taVNS on Functional Mobility in People With DP

Not Yet Recruiting
NCT06927024Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

Recruiting
NCT06763913Not Applicable

taVNS Reduces Postoperative Pain and Complications in Patients With Gastric and Intestinal Tumors

Completed
NCT07017257Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Persistent Post-concussion Symptoms

Recruiting
NCT05254080Not Applicable

taVNS Cold Pressor

Completed
NCT05943431Not Applicable

taVNS Paired With Motor Training for Upper-extremity Rehabilitation in Stroke Patients

Unknown

Drug Details

Intervention Type
DEVICE
Total Trials
23